MyFinsight
Home
About
Contact
acrs: the income statement
Download
Download image
Unrealized gain on
marketable securities, net...
$115K
(-87.08%↓ Y/Y)
Comprehensive loss
-$14,499K
(-116.53%↓ Y/Y)
Total other
comprehensive income
$115K
(-87.08%↓ Y/Y)
Non-cash royalty income
$716K
(-19.91%↓ Y/Y)
Interest income
$1,819K
(-8.64%↓ Y/Y)
Net loss
-$14,614K
(-92.64%↓ Y/Y)
Total other income
$2,535K
(-12.13%↓ Y/Y)
License And Service
$2,814K
Laboratory Research
Revenue
$485K
Loss from operations
-$17,149K
(-63.78%↓ Y/Y)
Total revenue
$3,299K
(-24.09%↓ Y/Y)
Total costs and
expenses
$20,448K
(38.00%↑ Y/Y)
Revaluation of contingent
consideration
$100K
(-87.50%↓ Y/Y)
Licensing
$1,911K
(8.95%↑ Y/Y)
General and
administrative
$4,871K
(-13.83%↓ Y/Y)
Research and development
$13,028K
(118.74%↑ Y/Y)
Cost of revenue
$538K
(-17.74%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)